コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 vation and lineage specification of resident cardiac stem cells.
2 nous regeneration via activation of resident cardiac stem cells.
3 properties have been demonstrated for human cardiac stem cells.
4 n(-) c-kit(POS) cells with the properties of cardiac stem cells.
6 ther with fundamental scientific advances in cardiac stem cell and regenerative biology, are beginnin
9 dissected in terms of the critical role that cardiac stem cells and myocyte regeneration play in the
10 rogenitors, mesenchymal stem cells, resident cardiac stem cells, and both mouse and human embryonic s
11 es and vasculature cells, recruit endogenous cardiac stem cells, and secrete a wide array of paracrin
12 mulation of A2B adenosine receptors on mouse cardiac stem cell antigen (Sca)-1(+)CD31(-) mesenchymal
13 en intravenously after ischemia/reperfusion, cardiac stem cell antigen 1 cells home to injured myocar
15 egeneration by the infused MSC or endogenous cardiac stem cells based on lack of evidence for cardiac
17 in the heart, c-kit is expressed not only by cardiac stem cells but also by cardiomyocytes, commencin
18 ency is attributable to the lack of resident cardiac stem cells, combined with roadblocks that limit
19 quired for stem cell activation, but whether cardiac stem cell (CSC) function is regulated by the hyp
20 Importantly, the consequences of aging on cardiac stem cell (CSC) growth and senescence were evalu
21 e tested whether the human heart possesses a cardiac stem cell (CSC) pool that promotes regeneration
22 We hypothesized that the growth reserve of cardiac stem cells (CSCs) and circulating cytokines prom
23 al of this study is to characterize resident cardiac stem cells (CSCs) and investigate their therapeu
25 liferation and differentiation of endogenous cardiac stem cells (CSCs) as part of their regenerative
27 neage, and overexpression of Pim1 in ckit(+) cardiac stem cells (CSCs) enhances their cardioreparativ
31 ulatory angiogenic cells (CACs) and resident cardiac stem cells (CSCs) have both been shown to improv
32 d mesenchymal stem cells (MSCs) and c-kit(+) cardiac stem cells (CSCs) improve left ventricular remod
34 s vein-derived pericytes (SVPs) with that of cardiac stem cells (CSCs) in a model of myocardial infar
35 zed, open-label trial of autologous c-kit(+) cardiac stem cells (CSCs) in patients with heart failure
36 roliferation and differentiation of c-kit(+) cardiac stem cells (CSCs) in vivo and in vitro, we hypot
38 tus on the cardiac regenerative potential of cardiac stem cells (CSCs) is unknown yet critical, given
41 autologous mesenchymal stem cells (MSCs) and cardiac stem cells (CSCs) synergistically reduces scar s
42 ether the mouse heart at birth has a pool of cardiac stem cells (CSCs) that differentiate into myocyt
43 ate that HDAC inhibition stimulates c-kit(+) cardiac stem cells (CSCs) to facilitate myocardial repai
49 tly linked to cardiomyogenesis and embryonic cardiac stem cell development and differentiation but ne
50 tify novel functions for c-kit: promotion of cardiac stem cell differentiation and regulation of card
51 d in cardiac hypertrophy, heart development, cardiac stem cell differentiation, and arrhythmias throu
53 positive (c-Kit(+)), CD45-negative (CD45(-)) cardiac stem cells (eCSCs) from whole adult mouse and ra
54 ult myocardium harbors endogenous c-kit(pos) cardiac stem cells (eCSCs), whose relevance for regenera
55 ence of a novel population of resident adult cardiac stem cells expressing PW1(+) and their involveme
57 the past two decades, several populations of cardiac stem cells have been described in the adult mamm
58 e of these properties, bone marrow cells and cardiac stem cells have been employed experimentally in
61 tracoronary delivery of c-kit-positive human cardiac stem cells (hCSCs) is a promising approach to re
62 A progressive loss of telomeric DNA in human cardiac stem cells (hCSCs) occurs with aging and the new
67 f intracoronary delivery of allogeneic human cardiac stem cell in 55 patients with large acute myocar
68 a novel experience in humans with allogeneic cardiac stem cell in a rigorously imaging-based selected
69 a promising preclinical background, CAREMI (Cardiac Stem Cells in Patients With Acute Myocardial Inf
71 different populations of embryonic and adult cardiac stem cells, including KIT(+), PDGFRalpha(+), ISL
72 Overexpression of nucleostemin in cultured cardiac stem cells increases proliferation while preserv
75 othelial, and mesenchymal lineages, putative cardiac stem cell markers, and, interestingly, cardiomyo
76 as thought to be impossible, but multipotent cardiac stem cells may be able to renew the myocardium a
78 We report that the dog heart possesses a cardiac stem cell pool characterized by undifferentiated
83 e clusters strongly support the existence of cardiac stem cells that amplify and commit to the myocyt
84 ell compartment characterized by multipotent cardiac stem cells that possess the ability to acquire t
86 , two causes of low survivability in current cardiac stem cell therapies, mechanical and metabolic, w
90 recent debates-the contribution of c-Kit(+) cardiac stem cells to cardiomyocytes in the heart and th
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。